País: Unión Europea
Idioma: portugués
Fuente: EMA (European Medicines Agency)
Istradefylline
Kyowa Kirin Holdings B.V.
N04
istradefylline
Anti-Parkinson
Doença de Parkinson
Istradefylline is indicated in adults as an adjunctive treatment to levodopa based regimens in patients with Parkinson’s disease (PD) experiencing “OFF” time.
Recusou